Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
Partnership to accelerate enrollment and diversity in neurovascular clinical research. SAN FRANCISCO - November 16, 2022 - Viz.ai, the leader in...
Nov 16, 2022
Press & News
Explore our News & Press
Viz.ai Partners with Illuminate to Improve Quality of Care for Aortic Aneurysm Patients
Adds natural language processing to Viz.ai’s AI-powered platform to detect suspected disease earlier and monitor patients. SAN FRANCISCO – November 15,...
Nov 15, 2022
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F18⁸⁵ PE System...
AngioDynamics, The PERT Consortium™ and Viz.ai partner on APEX Study to facilitate future enrollment to bring innovative treatment to patients...
Oct 31, 2022
Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm
Part of the Viz PE Solution, new algorithm flags key patient risk indicator of pulmonary embolism severity. SAN FRANCISCO – September...
Sep 01, 2022
Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease
Diagnosis and care coordination of patients suffering from pulmonary embolism (PE) can be challenging, with the average arrival-to-treatment times lasting...
Nov 16, 2021
Viz.ai and Avicenna.AI Partner
Viz.ai, the world leader in AI-driven intelligent care coordination, haspartnered with Avicenna.AI, a global leader in artificialintelligence solutions, to enable...
Jul 15, 2021